Lithium Ion

Lithium Ion

SCHEMBL1036060

Cc1ccc(S(=O)(=O)[O-])cc1.[Li+]

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.62
CA1 P00915 4/20 0.56
CA2 P00918 4/20 0.56
CA12 O43570 2/20 0.56
CA9 Q16790 2/20 0.56
CA3 P07451 1/20 0.56
CA6 P23280 1/20 0.56
CA5A P35218 1/20 0.56
CA7 P43166 1/20 0.56
CA5B Q9Y2D0 1/20 0.56
TLR9 Q9NR96 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 4/20 0.50
TDP1 Q9NUW8 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
MMP1 P03956 1/20 0.50
MMP2 P08253 1/20 0.50
MMP9 P14780 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8954960 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL8943267 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL10663598 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL11815250 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL6917586 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL2138368 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL8617002 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL20583857 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL22615914 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL6034154 0.94 GAA (0.62) GAACA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119029167-B Preparation method and application of silicon-carbon composite material 湖北斯诺新材料科技有限公司 2025-05-16 CN claimed
WO-2025063737-A1 METHOD FOR PREPARING SUBSTITUTED FUSED IMIDAZOLE DERIVATIVE YUNOVIA CO., LTD. (KR) 2025-03-27 WO claimed
CN-119650644-A Composite anode material and preparation method and application thereof 蜂巢能源科技股份有限公司 2025-03-18 CN claimed
CN-119601634-A Quick-charging low-temperature graphite composite material, preparation method and application thereof 广东宏璟新能源科技有限公司 2025-03-11 CN claimed
CN-119419356-A Electrolyte and lithium ion battery 上海轩邑新能源发展有限公司 2025-02-11 CN claimed
CN-119280450-A Medical fabric dressing with long-acting disinfection and sterilization functions and preparation method thereof 孙国明 2025-01-10 CN claimed
CN-119170772-A Lithium silicate/organic lithium coated silicon carbon composite material and preparation method thereof 贵州晖阳科技创新研究有限公司 2024-12-20 CN claimed
CN-119029167-A Preparation method and application of silicon-carbon composite material 湖北斯诺新材料科技有限公司 2024-11-26 CN claimed
CN-118844448-A Preparation method of long-acting antibacterial liquid 孙国明 2024-10-29 CN claimed
CN-118844836-A Long-acting disinfection and sterilization wet (towel) paper 孙国明 2024-10-29 CN claimed
WO-2005026168-A1 METHOD FOR PREPARING CUCURBITURILS UNISEARCH LIMITED (AU) 2005-03-24 WO claimed
US-6793839-B1 FORMING METHYLENE BRIDGES BETWEEN GLYCOLURIL UNITS; ATTAINING OLIGIMERS WITH UP TO TWELVE UNITS AT HIGH YIELD UNISEARCH LIMITED (AU) 2004-09-21 US claimed
US-6677483-B2 DISSOLVING DIETHYLENETRIAMINEPENTAACETIC- BISANHYDRIDE OF FORMULA IN DIMETHYL SULFOXIDE OR IN DIMETHYLFORMAMIDE OR IN A MIXTURE; ADDING SOLUBILIZER, AN AUXILIARY BASE AND A MONOAMINE OR DIAMINE, HEATING SCHERING AG (DE) 2004-01-13 US claimed
EP-1181293-A4 CUCURBITURILS AND METHOD FOR SYNTHESIS UNISEARCH LTD (AU) 2003-06-11 EP claimed
US-20020155065-A1 Process for the production of monoamides of DTPA SCHERING AG (DE) 2002-10-24 US claimed
EP-1181293-A1 CUCURBITURILS AND METHOD FOR SYNTHESIS UNISEARCH LIMITED (AU) 2002-02-27 EP claimed
WO-2001077205-A1 SALTS OF ARYL SULFONIC ACIDS AS CATALYSTS FOR THE PREPARATION OF POLYCARBONATES GENERAL ELECTRIC COMPANY (US) 2001-10-18 WO claimed
US-6184335-B1 HEATING, IN ONE OR MORE STAGES, MIXTURE COMPRISING DIPHENOL AND DIARYLCARBONATE; IN THE SAME STAGE OR DIFFERENT STAGES INTRODUCING CATALYTICALLY EFFECTIVE AMOUNT OF AN ALKALI AND/OR ALKALI EARTH METAL SALT OF ARYL SULFONIC ACID GENERAL ELECTRIC COMPANY 2001-02-06 US claimed
WO-2000068232-A1 CUCURBITURILS AND METHOD FOR SYNTHESIS UNISEARCH LIMITED (AU) 2000-11-16 WO claimed
US-3988159-A Light-sensitive material containing nitrone for forming heat-fixed images AMERICAN CAN COMPANY (US) 1976-10-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020155065-A1 Process for the production of monoamides of DTPA NAAA, PAM, DNPEP GAA 932/4885CA1 207/4885CA2 404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.